abstract |
The present invention relates to compounds of formula (I) used as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the usefulness of such compounds in inhibiting HCV NS5A activity, treating or preventing HCV infection, and in cell-based systems Use in inhibiting HCV viral replication and/or viral production. (I) |